Welch & Forbes LLC decreased its stake in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) by 5.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 9,045 shares of the company’s stock after selling 500 shares during the period. Welch & Forbes LLC’s holdings in […]
Solstein Capital LLC reduced its holdings in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) by 9.5% in the fourth quarter, Holdings Channel.com reports. The fund owned 16,820 shares of the company’s stock after selling 1,764 shares during the quarter. Novo Nordisk A/S comprises about 1.9% of Solstein Capital LLC’s portfolio, making the stock […]
180 Wealth Advisors LLC lessened its holdings in Novo Nordisk A/S (NYSE:NVO – Get Rating) by 7.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 4,485 shares of the company’s stock after selling 369 shares during the period. 180 Wealth Advisors LLC’s holdings in Novo Nordisk A/S were worth $617,000 as of its […]
Alera Investment Advisors LLC decreased its holdings in Novo Nordisk A/S (NYSE:NVO – Get Rating) by 2.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,957 shares of the company’s stock after selling 178 shares during the period. […]
Private Ocean LLC lessened its stake in Novo Nordisk A/S (NYSE:NVO – Get Rating) by 8.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,150 shares of the company’s stock after selling 105 shares during the quarter. Private Ocean LLC’s holdings in […]